$ICAD
Icad Inc
PRICE
$1.33 ▲3.906%
Extented Hours
VOLUME
250,104
DAY RANGE
1.27 - 1.37
52 WEEK
1.05 - 4.59
Key Metrics
Market Cap
33.33 M
Beta
0.88
Avg. Volume
167.25 K
Shares Outstanding
25.45 M
Yield
0%
Public Float
0
Next Earnings Date
2023-08-10
Next Dividend Date
Company Information
icad is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. icad offers a comprehensive range of high-performance, upgradeable cad solutions for mammography and advanced image analysis and workflow solutions for magnetic resonance imaging, for breast and prostate cancers and computed tomography for colorectal cancer. icad’s xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. the xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. for more information, call 877-icadnow, or visit www.icadmed.com.
Website: icadmed.com
HQ: ,
Related News